Le Lézard
Classified in: Health, Business
Subjects: MAV, ECO, CPG, CFG

/R E P E A T -- Media advisory - Government of Canada to announce major milestone achieved in Canadian biomanufacturing and life sciences sector/


LAVAL, QC, Feb. 22, 2024 /CNW/ - The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, the Honourable Mark Holland, Minister of Health, and the Honourable Jean-Yves Duclos, Minister of Public Services and Procurement, as well as Pierre Fitzgibbon, Quebec Minister of Economy, Innovation and Energy, Minister Responsible for Regional Economic Development and Minister Responsible for the Metropolis and the Montréal Region, Christopher Skeete, Quebec Minister for the Economy, Minister Responsible for the Fight Against Racism and Minister Responsible for the Laval Region, and Stéphane Boyer, Mayor of Laval, will mark a major milestone for Moderna's new state-of-the-art mRNA vaccine production facility in Laval, Quebec, with a tour of the facility for dignitaries and media representatives, followed by a media scrum.

Date: Friday, February 23, 2024

Time: 10:00 am to noon

Note for media
Members of the media are asked to contact ISED Media Relations at [email protected] to confirm their attendance and receive event location details.

Stay connected

Find more services and information at Canada.ca/ISED.

Follow Innovation, Science and Economic Development Canada on social media.
X (Twitter): @ISED_CA, Facebook: Canadian Innovation, Instagram: @cdninnovation and LinkedIn

SOURCE Innovation, Science and Economic Development Canada


These press releases may also interest you

at 06:00
Brazilian Doctor Ushering in New Era of Medical Technology for Treating Cancer and Seeks to Bring Proton Therapy to Brazil
A native born and trained Brazilian oncologist is in the forefront of a new era in the treatment of cancer patients with cutting edge proton therapy medical technology developed in Israel by P-Cure. "It is my dream to be able to bring the P-Cure...

4 mai 2024
UroGen Announces Results from ATLAS Showing Robust UGN-102 Durability of Response in New and Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer at AUA 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
New Real-World Study on Retrograde Instillation of JELMYTO® for Treatment of Low-Grade Upper Tract Urothelial Cancer Reports Similar Complete Response Rate and Lower Stricture Rate Compared to OLYMPUS Pivotal Trial
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
Celebrate Women's Heart Health Month With Gundry MD Energy Renew
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...

4 mai 2024
RaySearch and C-RAD sign collaboration agreement
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...

4 mai 2024
Second Opinion Expert Announces OC FERTILITY® + OC BIOGENIX® To Join Its Panel To Provide Expert Second Opinions.
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility...

More news about Health...


News published on and distributed by: